Matthew Schiesher

Jan 11, 2025 | outsourcedpharma.com | Louis Garguilo |Matthew Schiesher |Sticky Formulations

We’re ready to help usher your next drug into market! 2025’s first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry’s best and give you complimentary VIP access to the resources available to support your success.

Jan 7, 2025 | drugdiscoveryonline.com | Peter H. Calcott |Matthew Schiesher

FDA's CDER recently issued a draft guidance: Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics. This article provides a summary and analysis. The public comment period ends January 14, 2025. Innovative AI-Driven Solutions To Address The Growing Complexity Of APIsComputer-aided synthesis planning (CASP) can mitigate the impact of rising complexity. We discuss the award-winning AI and vast data that propel a leading predictive retrosynthesis technology.

Sep 26, 2023 | pharmaceuticalonline.com | Peggy Lio |Miranda Kheradmand |Matthew Schiesher |Tyler Harris

Webinar: Planning For Success — Supply Resiliency Strategies For Bench To ProductionUnderstanding the key criteria for raw material selection early in process development is vital for accelerating the development process and ensuring the scalability of your biologics. In this webinar, Thermo Fisher Scientific strategic chemical sourcing experts will discuss best practices and considerations for building scalable material sourcing strategies for R&D and early phases through to commercialization.